new proton pump inhibitor called Nexium

AstraZeneca has their marketing machine in high gear for their new proton pump inhibitor called Nexium.

AstraZeneca just released Nexium in the U.S. as the follow-up to Losec...because the U.S. patent for Losec expires later this year.

Nexium is still being considered in Canada.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote